Trial intelligence / Profile preview

Etomidate vs Propofol in Cardiac Surgery

NCT00415701Phase 4Completed

Sponsor
Insel Gruppe
Start
Nov 2006
Primary completion
Dec 2009
Modality
Small Molecules
Countries
1
01

Overview

A Phase 4 trial of etomidate in coronary artery disease (CAD), mitral valve regurgitation (MR), sponsored by Insel Gruppe. Started Nov 2006; status: completed.

02

Drugs

etomidate
03

Conditions

coronary artery disease (CAD)mitral valve regurgitation (MR)

Beyond the preview

Go deeper on NCT00415701.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00415701.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call